InsidersTradesSigma
Explore the complete record of transactions filed by Hanna Olsson, Chief Financial Officer. Officer active across 2 companies, notably Spago Nanomedical AB (publ). In total, 1 disclosures have been published. The latest transaction was disclosed on 21 November 2025 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
1 of 1 declaration
Hanna Olsson is the Chief Financial Officer at Spago Nanomedical AB (publ). She is responsible for the company's financial management, including budgeting and financial reporting. With a strong background in finance, Hanna plays a key role in strategic decision-making that influences Spago's financial health. Her expertise is essential for ensuring transparency and compliance.